All Stories

  1. Binding, selectivity and sequence recognition of matrix metalloproteinase-2 to oligopeptides
  2. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
  3. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines
  4. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
  5. Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization
  6. Dual Receptor-Specific Peptides Modified Liposomes as VEGF siRNA Vector for Tumor-Targeting Therapy